# The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)

> **NCT03180450** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Sclnow Biotechnology Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)
- **DRUG:** conventional treatment

## Key facts

- **NCT ID:** NCT03180450
- **Lead sponsor:** Sclnow Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-12-31
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Others
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180450, "The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03180450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*